Axiom Therapeutics
ActiveAI-nativeAI-powered covalent drug discovery for untreatable cancers
What it does
Axiom Therapeutics is a pioneering health tech company specializing in AI-powered covalent drug discovery for untreatable cancers. Utilizing cutting-edge technology, Axiom develops machine learning-accelerated physics simulations to predict the interaction between covalent drugs and disease-causing proteins. By leveraging computational drug discovery, Axiom aims to revolutionize cancer treatment by identifying novel therapeutic solutions for currently untreatable forms of the disease. The company's innovative approach to drug development holds the potential to significantly impact the field of oncology by offering new treatment options and improving patient outcomes. Axiom Therapeutics is at the forefront of innovation in the healthcare industry, driving advancements in precision medicine and personalized cancer therapies.
Its site says now · captured 2026-08-23
Axiom Therapeutics - Unlocking Covalent Drug Discovery
Pioneering next generation therapeutics through cutting-edge research and AI-powered drug discovery
Next to it in Healthcare and bio · AI-powered drug discovery for cancer
- Harmonic DiscoveryY Combinator S21
Multi-targeted therapeutics to treat complex diseases
- CytodymeTechstars TS 2025
Cytodyme
- ConvexiaY Combinator S25
The world's first AI-maximalist pharma company
- Ångström AIY Combinator S24
Gen AI molecular simulations that reproduce wetlab results
- PaulingPlug and Play PnP 2025
Next-generation molecular simulation platform for drug discovery.
- Ditto BiosciencesY Combinator W26
Evolutionary intelligence for autoimmune disease
- WonderTxY Combinator S26
Extrapolative AI to unlock First-in-Class drugs
- AMPLY DiscoveryTechstars TS 2023
AMPLY Discovery — Turning the Dark Genome into Novel Medicines